Impact of the 2013 National Rollout of CMS Competitive Bidding Program: The Disruption Continues.
Gary A PuckreinIrl B HirschChristopher G ParkinBruce T TaylorLiou XuDavid G MarreroPublished in: Diabetes care (2017)
Disruption of beneficiary access to their prescribed SMBG supplies has persisted and worsened. Diabetes testing supplies should be excluded from the CBP until transparent, science-based methodologies for safety monitoring are adopted and implemented.